Neuronostatin-13 human is primarily studied for its role in regulating physiological processes, particularly in the cardiovascular and nervous systems. It has been shown to influence blood pressure by inducing vasoconstriction, making it a potential target for research in hypertension management. Additionally, it plays a role in modulating insulin secretion, which could have implications for diabetes research. In the central nervous system, it is involved in stress responses and may contribute to the regulation of appetite and energy balance, suggesting potential applications in metabolic disorder studies. Its effects on neuronal activity also make it a candidate for exploring treatments for neurological conditions.